FEATURED CONTRIBUTED CONTENT
While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to brand marketing have been largely ignored. But in the new multistakeholder-driven environment that requires brands to stay one step ahead, Mark Sales and Fabrice Bourg ask whether marketing has to address unrealized brand opportunity or face extinction. Is brand marketing dead?
Risk Based Monitoring (RBM) requires new monitoring skills, new analytic approaches, new staffing models, and new clinical operation processes. While many economic and qualitative reasons mandate adopting RBM, companies usually find it overwhelming to implement such a widespread change. This webinar covers an approach that enables companies to adopt RBM while minimizing disruption to its current processes and contractual commitments.
In this episode, you’ll hear a conversation with Dr. Kathleen Starr, a psychologist and leader of a team of behavioral scientists at inVentiv Health. Kathleen is interviewed by Sydney Rubin, a senior communications consultant with inVentiv Health. You are also encouraged to download a complementary white paper on ethnography.
In this episode, Mark Sales discusses pharma brand marketing, product marketing, B2B vs. B2C, and how pharma marketers can make improvements in traditional areas of weakness. You can also download a related white paper on pharma brand marketing.
Is ‘Patient Centricity’ just a buzz word or is it here to stay? Join the conversation as scientists, technologists and patients discuss and debate the future possibilities of patient centricity in clinical research in three original videos. Learn practical ways to help improve patient satisfaction and operational results. Be inspired as a patient shares firsthand […]
While oral anticancer treatments are convenient for patients, patient adherence to treatment is a significant issue. Patients need support to remain adherent and maximize treatment outcomes. There are many factors that contribute to patient non-adherence to oral anticancer treatments, and increasing patient adherence to treatment requires multi-faceted solutions. Patient and family education has been shown […]
How creative life-cycle management can protect your bottom line. Creative life-cycle management is the key to maximizing your brand’s profitability. Several factors play into this strategy. An article in the November/December issue of PharmaVOICE magazine covers the following concepts: Reformulation 101 – reformulation strategies Creative Combinations Offer New Opportunities Making Old Drugs New Again Speed […]
In this episode, Kevin D. Duffy discusses sourcing talent in the life science industry, strategic partnering for acquiring talent, the concept of talent supply chain management, and a glimpse into the future.
In this OnDemand webinar, Dr. Neil Singla, Chief Scientific Officer of Lotus Clinical Research, LLC discusses techniques to mitigate placebo response phenomenon. The discussion focuses on bias reduction through education of the study subject and key research personnel.
Why understanding possible future worlds is essential to maximizing product commercialization success
Pharma companies seeking to maximize their Return on Investment (ROI) have to accept that their planning must deal with multiple potential futures. The goal is not to predict a single most likely (or hoped for) future. Rather, it is to determine the most probable range of future scenarios for a product. Learn more in this informative white paper.
From Enrollment to Launch – Why a Comprehensive Marketing Strategy is Critical Throughout Drug Development
The pharmaceutical industry has never faced higher financial stakes than it does today, and overcoming modern obstacles requires a contemporary approach that encompasses all aspects of clinical research, pre-market approval, and the market release process. You need a solid marketing strategy. Patients are the driving force in modern healthcare, and marketing efforts should adopt patient perspectives […]
A special publication brought to you by the Healthcare Businesswomen’s Association. Celebrating 35 years of the HBA. Connect. Share. Grow.
Healthcare marketers will find that insights from ethnographic research could mean the difference between the success or failure of their efforts to change behavior. Find out more in this informative white paper. There is also a related podcast on this topic.
Artcraft Health recently updated its website, to better serve the interests of its clientele in the life sciences industry, including pharma, biotech, and medical device companies. Here’s a quick company overview—They are an award-winning, full-service health education agency specializing in the creation and development of compelling solutions that are aligned with their clients’ strategic imperatives. […]
Life science companies are effecting a paradigm shift in their focus towards emerging markets driven by the growing economies of these markets and the steady decline of growth opportunities in the developed markets.